Nils-Göran Larsson

Title: Nils-Göran Larsson: Innovator in Cancer Treatment

Introduction

Nils-Göran Larsson is a notable inventor based in Sollentuna, Sweden. He has made significant contributions to the field of cancer treatment through his innovative research and development of novel compounds. With a total of three patents to his name, Larsson's work focuses on enhancing therapeutic options for cancer patients.

Latest Patents

Larsson's latest patents include groundbreaking inventions such as coumarin derivatives, which serve as specific mitochondrial RNA polymerase inhibitors for cancer treatment. This invention provides novel compounds that can potentially improve the efficacy of cancer therapies. Another significant patent involves a method to detect the activity of a polymerase. This invention relates to methods for detecting nucleotide polymerase activity and identifying compounds that modulate this activity. The method utilizes proximity-dependent energy transfer techniques, such as Förster resonance energy transfer, to determine the interaction between labeled nucleotide probes.

Career Highlights

Throughout his career, Nils-Göran Larsson has worked with esteemed organizations, including Lead Discovery Center GmbH and Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. His work in these institutions has allowed him to advance his research and contribute to the scientific community significantly.

Collaborations

Larsson has collaborated with notable colleagues, including Tim Bergbrede and Maria Falkenberg-Gustafsson. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to impactful discoveries.

Conclusion

Nils-Göran Larsson's contributions to cancer treatment through his innovative patents and collaborations highlight his role as a significant inventor in the field. His work continues to inspire advancements in medical research and therapeutic development.